Project Number 1R35NS127327-01 Agency/Funding Organization NINDS Funding Year 2022 View Full Project Details for Molecular Mechanisms Underlying Cell Type-Specific Vulnerability in Huntington’s Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 17. Genetics e. Nucleic acid-related "omics" Studies Researcher and Organization Principal Investigator HEIMAN, MYRIAM Principal Investigator First Name MYRIAM Principal Investigator Last Name HEIMAN Awardee Organization MASSACHUSETTS INSTITUTE OF TECHNOLOGY Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-NS-21-020: Research Program Award (R35 Clinical Trial Optional) FY Overall Cost $542,850 Funding Organization Agency/Funding Organization NINDS Funding Organization Country United States Program Official MILLER, DANIEL L
